Related Experiment Video
Updated: May 2, 2026

An Integrated Platform for Genome-wide Mapping of Chromatin States Using High-throughput ChIP-sequencing in Tumor Tissues
Published on: April 5, 2018
Keep-ING balance: tumor suppression by epigenetic regulation
Gesche Tallen1, Karl Riabowol2
1Dept. of Pediatric Oncology/Hematology, Charité-Medical School Berlin, Germany.
Abstract:
Cancer cells accumulate genetic and epigenetic changes that alter gene expression to drive tumorigenesis. Epigenetic silencing of tumor suppressor, cell cycle, differentiation and DNA repair genes contributes to neoplastic transformation. The ING (inhibitor of growth) proteins (ING1-ING5) have emerged as a versatile family of growth regulators, phospholipid effectors, histone mark sensors and core components of HDAC1/2 - and several HAT chromatin-modifying complexes. This review will describe the characteristic pathways by which ING family proteins differentially affect the Hallmarks of Cancer and highlight the various epigenetic mechanisms by which they regulate gene expression. Finally, we will discuss their potentials as biomarkers and therapeutic targets in epigenetic treatment strategies.
Insights
Inhibitor of growth (ING) proteins regulate gene expression through epigenetic mechanisms, impacting cancer development. These proteins show potential as biomarkers and therapeutic targets for epigenetic cancer treatments.
Area of Science:
- Oncology
- Epigenetics
- Molecular Biology
Background:
- Cancer arises from genetic and epigenetic alterations affecting gene expression.
- Epigenetic silencing of key genes promotes neoplastic transformation.
- ING (inhibitor of growth) proteins are crucial regulators involved in various cellular processes.
Purpose of the Study:
- To review the roles of ING proteins in cancer development.
- To highlight the epigenetic mechanisms regulated by ING proteins.
- To discuss the potential of ING proteins as biomarkers and therapeutic targets.
Main Methods:
- Literature review of studies on ING proteins and cancer.
- Analysis of epigenetic regulatory pathways involving ING proteins.
- Evaluation of ING proteins in the context of the Hallmarks of Cancer.
Main Results:
- ING proteins (ING1-ING5) function as growth regulators and chromatin modifiers.
- They interact with HDAC and HAT complexes, influencing gene expression.
- ING proteins differentially impact the Hallmarks of Cancer via epigenetic mechanisms.
Conclusions:
- ING proteins are versatile regulators with significant roles in tumorigenesis.
- Their involvement in epigenetic gene regulation presents therapeutic opportunities.
- ING proteins hold promise as biomarkers and targets for epigenetic cancer therapies.
Related Concept Videos
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Epigenetic Regulation
Abnormal Proliferation

